MA04.03 A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor (KCSG LU17-21)

MLA

Keon Uk Park, et al. “MA04.03 A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor (KCSG LU17-21).” Journal of Thoracic Oncology, vol. 16, Oct. 2021, pp. S896–97. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9029c40af7b5ff59f19dbfb2db25e3c5&authtype=sso&custid=ns315887.

APA

Keon Uk Park, S.H. Park, M-J. Ahn, Jwa-Jin Kim, Joonghyun Ahn, Yoon Hee Choi, Hyun Ae Jung, Min Seon Kim, S.J. Lee, Jungkeun Park, K. Park, Ji-Suk Cho, & Jong-Mu Sun. (2021). MA04.03 A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor (KCSG LU17-21). Journal of Thoracic Oncology, 16, S896–S897.

Chicago

Keon Uk Park, S.H. Park, M-J. Ahn, Jwa-Jin Kim, Joonghyun Ahn, Yoon Hee Choi, Hyun Ae Jung, et al. 2021. “MA04.03 A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor (KCSG LU17-21).” Journal of Thoracic Oncology 16 (October): S896–97. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9029c40af7b5ff59f19dbfb2db25e3c5&authtype=sso&custid=ns315887.